Weekly paclitaxel, carboplatin and cetuximab (PCE) combination followed by nivolumab for recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)
- Naohiro Takeshita
- , Tomohiro Enokida
- , Susumu Okano
- , Takao Fujisawa
- , Akihisa Wada
- , Masanobu Sato
- , Hideki Tanaka
- , Nobukazu Tanaka
- , Ryutaro Onaga
- , Yuta Hoshi
- , Shingo Sakashita
- , Genichiro Ishii
- , Makoto Tahara
Research output: Contribution to journal › Article › peer-review
1
Scopus
citations